Instituto de Cardiologia do Instituto de Cardiologia do Rio Grande do Sul / Fundação Universitária de Cardiologia (IC/FUC)o Grande do Sul / Fundação Universitária de Cardiologia (IC/FUC)
Porto Alegre, Rio Grande do Sul, Brazil
NCT Number: NCT07127640
Hypertrophic cardiomyopathy is a genetic heart disease with symptoms that may include dyspnea and fatigue predominantly on exertion, with or without chest pain, palpitations, syncope/presyncope and sudden cardiac death, mostly in young individuals, often without symptoms. Due to the higher cardiovascular risk described for individuals with hypertrophic cardiomyopathy, it is extremely important to create non-pharmacological strategies that can minimize the evolution of cardiovascular risk factors found in this population. The objective of the study will be to evaluate the effect of an aerobic exercise session on the ratio between the low frequency (LF) and high frequency (HF) bands of heart rate variability, endothelial function through flow-mediated dilation and systolic and diastolic blood pressure during the 24-hour period in adult individuals with hypertrophic cardiomyopathy. The study design will be a randomized crossover clinical trial with individuals aged 18 to 59 years, of both sexes, randomized by lottery and divided into two groups: Exercise group and control group without exercise. An exercise stress test will be performed and on a new date the individuals will perform a supervised session of moderate-intensity aerobic exercise on a horizontal stationary bicycle for 50 minutes or will remain seated in an air-conditioned room for the same period of time. Subsequently, the procedures will be crossed. It is expected to find improvements in the parameters of endothelial function, autonomic modulation and 24-hour blood pressure in adult individuals with non-obstructive hypertrophic cardiomyopathy undergoing a session of aerobic physical exercise when compared to a control session without exercise.
This study is active but is not currently recruiting participants.
Notify Me18 year–59 year
All sexes
Interventional
Not applicable
Porto Alegre, Rio Grande do Sul, Brazil
Healthy volunteers accepted: No
Only the study team can determine whether someone qualifies for participation.
Inclusion criteria
Exclusion criteria
An aerobic exercise session on a recumbent exercise bike with a 5-minute warm-up period, followed by a 40-minute cool-down period and ending with a 5-minute cool-down at decreasing speed.
Time frame: From enrollment to the end of treatment at 2 weeks
Ratio between the low frequency (LF) and high frequency (HF) bands of heart rate variability by electrocardiogram
Time frame: From enrollment to the end of treatment at 2 weeks
Flow-mediated dilation (FMD) by high-resolution Doppler ultrasound images of the brachial artery.
Time frame: From enrollment to the end of treatment at 2 weeks
Ambulatory Blood Pressure Monitoring
Instituto de Cardiologia do Rio Grande do Sul
Other
Effect of an Aerobic Exercise Session on Cardiovascular and Autonomic Parameters of Adults With Hypertrophic Cardiomyopathy: a Randomized Clinical Trial
OpenTrials presents study information sourced from ClinicalTrials.gov. The official registry record should be consulted for the latest information.
View the official ClinicalTrials.gov record (opens in a new tab)This listing is for discovery and informational purposes only. It is not medical advice, does not guarantee that a study is recruiting, and does not determine eligibility. Contact the study team and a qualified healthcare professional when considering participation.
Published trials that share one or more normalized conditions with this study.
NCT01127061
Aortic Stenosis, Subvalvular, Aortic Valve Disease
Stanford, California, United States
View Trial DetailsNCT05524077
Aortic Stenosis, Subvalvular, Aortic Valve Disease
Camperdown, New South Wales, Australia
View Trial DetailsNCT06253221
Aortic Stenosis, Subvalvular, Aortic Valve Disease
Birmingham, Alabama, United States
View Trial DetailsNCT06112743
Aortic Stenosis, Subvalvular, Aortic Valve Disease
West Hollywood, California, United States
View Trial Details